Kiromic BioPharma Inc. (KRBP)
0.80
0.00 (0.00%)
At close: Jan 24, 2025, 2:14 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 1.23M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -6.22 |
| PE Ratio (ttm) | -0.13 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 4,898 |
| Avg. Volume (20D) | 1,659 |
| Open | 0.80 |
| Previous Close | undefined |
| Day's Range | 0.80 - 0.80 |
| 52-Week Range | 0.75 - 3.78 |
| Beta | undefined |
About KRBP
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candi...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 16, 2020
Employees 35
Stock Exchange NASDAQ
Ticker Symbol KRBP
Website https://www.kiromic.com
